Background: To the present day infective endocarditis (IE) represents a life-threatening disease with high mortality rate especially when caused by Staphylococcus aureus (S. aureus), the most common causative pathogen in this disease. Diagnosis of IE is based on clinical manifestations, pathogen detection by blood cultures and echocardiographic or other imaging findings.
View Article and Find Full Text PDFGiven the clinical potential of poly(ADP-ribose) polymerases (PARP) imaging for the detection and stratification of various cancers, the development of novel PARP imaging probes with improved pharmacological profiles over established PARP imaging agents is warranted. Here, we present a novel F-labeled PARP radiotracer based on the clinically superior PARP inhibitor talazoparib. An automated radiosynthesis of [F]talazoparib (RCY: 13 ± 3.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
February 2022
Purpose: Imaging of PARP expression has emerged as valuable strategy for prediction of tumor malignancy. While [F]PARPi and [F]FTT are already in clinical translation, both suffer from mainly hepatobiliary clearance hampering their use for detection of abdominal lesions, e.g.
View Article and Find Full Text PDF